EUVIMEDEUVIMED entdecken
Crossref

Standardizing periprocedural anticoagulation management: a stewardship initiative

Kelly Rudd, Amanda Winans, Darren Triller

Journal of Thrombosis and Thrombolysis · 2023

DOI: 10.1007/s11239-023-02854-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Thrombolysis, 2023. Verfasst von Kelly Rudd und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oklahoma State University Center for Health Sciences Tulsa, Oklahoma, USA. kelly.rudd@okstate.edu. Hauptthemen laut MEDLINE: Anticoagulants, Warfarin, Thrombosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Study data indicates anticoagulant interruption peri-procedurally can increase the risk of anticoagulation-related bleeding and thrombosis. Management of anticoagulated patients during the peri-procedural period poses clinical challenges given the potential for thrombosis and bleeding in this complex, high risk population. As such, there is a need for enhanced emphasis on anticoagulated patient care throughout the peri-procedural period with the goal of optimizing patient safety and efficacy. PURPOSE: To operationalize an effective, efficient, comprehensive, and standardized anticoagulation management peri-procedural process housed within the electronic health record (EHR). DESIGN: The IPRO-MAPPP clinical decision support logic was adapted into a nurse-managed protocol to guide anticoagulation therapy use during the elective peri-procedural period at Bassett Medical Center, an Anticoagulation Forum Center of Excellence. A second phase of this initiative endorsed peri-procedural warfarin and bridging management by the Anticoagulation Management Service. RESULTS: Outcomes revealed 30-day hospital or emergency department admissions remained at or below 1% of the surgical patient population, and below the published national standards for both phases of implementation. Further, no emergent anticoagulation reversal agent use was attributed to peri-procedural care during the assessment period. CONCLUSIONS: The phased implementation of this Anticoagulation Stewardship initiative in elective peri-procedural anticoagulation management successfully describes the operationalization and demonstration of high-quality care and low provider practice variation from policy. The integration of clinical decision support systems, in consort with effective communication, via the EHR, provides stability, sustainability, and drives high quality care to optimize patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsWarfarinThrombosisBlood CoagulationHemorrhageDecision Support Systems, ClinicalElectronic Health RecordsHumansPerioperative PeriodPerioperative Care

Stichwörter der Autor:innen

Adverse eventsAnticoagulantClinical Decision Support SystemsMedication safetyPeri-proceduralStewardship

Substanzen

AnticoagulantsWarfarin

Autor:innen und Institutionen

  • Oklahoma State University Center for Health Sciences Tulsa, Oklahoma, USA. kelly.rudd@okstate.edu.
  • Clinical Pharmacy Services, Bassett Healthcare Network, Cooperstown, NY, USA.
  • Anticoagulation Forum, Newton, MA, USA.

Zitieren

APA

Rudd, K., Winans, A., & Triller, D. (2023). Standardizing periprocedural anticoagulation management: a stewardship initiative. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-023-02854-2

Vancouver

Rudd K, Winans A, Triller D. Standardizing periprocedural anticoagulation management: a stewardship initiative. Journal of Thrombosis and Thrombolysis. 2023. doi:10.1007/s11239-023-02854-2

BibTeX
@article{Rudd2023,
  author = {Rudd, Kelly and Winans, Amanda and Triller, Darren},
  title = {Standardizing periprocedural anticoagulation management: a stewardship initiative},
  journal = {Journal of Thrombosis and Thrombolysis},
  year = {2023},
  doi = {10.1007/s11239-023-02854-2}
}
Kostenlos starten →